As discussions unfold, Kennedy seeks to balance drug accessibility with concerns about the long-term costs of providing GLP-1 ...

However, even with its relatively lower price compared to the US, the question remains — can she truly afford it? And if she ...

Scott MacMillan was relieved when doctors were able to save the life of his daughter, Rosemary, who was in diabetic ...

As obesity rates rise among individuals with T1D, GLP-1 agonist medications, indicated for T2D and weight loss, are ...

In the search for better ways to treat diabetes, researchers at the University of Geneva have uncovered a promising new ...

A retrospective study found that women who took a GLP-1 drug for obesity were more likely to be diagnosed with acne vulgaris ...

This popular spice is beloved by many, but its potential interactions with certain medications are important to be aware of.

Advocates for publicly funded coverage say there are detrimental and deadly health consequences for patients who cannot ...

GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a ...

According to Kiran Jones, a clinical pharmacist at Oxford Online Pharmacy, some of the most concerning side effects of GLP-1 ...

Novo Nordisk joined the many pharmaceutical companies pushing back on government-negotiated drug pricing in the United States.